<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03670875</url>
  </required_header>
  <id_info>
    <org_study_id>R-2016-785-103</org_study_id>
    <nct_id>NCT03670875</nct_id>
  </id_info>
  <brief_title>Non-Pharmacologic Alternatives for Childhood Obesity</brief_title>
  <official_title>Non-Pharmacologic Alternatives for the Treatment of Childhood Obesity in Mexico</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coordinación de Investigación en Salud, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coordinación de Investigación en Salud, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Childhood obesity is a global health issue. Mexico has been considered as the country with
      the higher number of children with obesity. There are not approved drugs to support diet and
      exercise as the first step to lose weight. Animal models and clinical trials in adults have
      provided evidence about safety and efficacy of interventions such as: prebiotics, curcumin,
      and omega- 3 fatty acids. The hypothesis of this study is: that non-pharmacological
      alternatives could support diet and exercise to decrease the weight of children with obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to determinate the efficacy and safety of agave inulin, curcumin,
      and omega-3 fatty acids (O3FA) to decrease the weight of children with obesity.

      Design. Randomized controlled clinical trial (RCT) with four study groups: agave inulin,
      curcumin, omega-3 fatty acids and a control group. All groups will receive instructions to
      decrease calories intake and do exercise.

      Children sent to the unit with a presumptive diagnosis of obesity will be considered as
      candidates to the RCT. Children accomplishing with inclusion/exclusion criteria will be
      randomized to one of the study groups.

      Sample size was calculated using a statistical power of 80%, alpha value of 0.05. A 15 % of
      difference, in the mean of weight reduction, between control group and intervention groups
      was considered. The estimated sample size was 75 subjects for each group.

      Weight, height, BMI, blood pressure, abdominal circumference and body fat percentage will be
      measured in months 0, 1, 2, and 3. In months 0 and 3 a fasting venous blood sample will be
      drawn to perform the following test: glucose, insulin, lipid profile and C- Reactive protein,
      aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Anthropometric measures,
      food intake recommendation and diaries of food consume will be performed by trained
      nutritionists. Recommendation about type of exercise and estimation of calories consumed will
      be performed by a physical education teacher.

      The statistical analysis will performed by one to the investigators blinded to treatment
      groups. Numerical values will be expressed as mean ± standard deviation. Categorical
      variables will be expressed as proportions. The analysis will be preformed according with
      CONSORT group recommendations Differences between the groups were estimated using one-way
      ANOVA with Bonferroni post-hoc test for numerical parameters and χ 2 test for categorical
      variables. Intragroup differences will be assessed by paired Student t test (Mann-Whitney U
      test for skewed data). Statistical significance will be considered as a p value &lt;0.05 and 95%
      confidence interval (CI). Statistical Package for the Social Sciences will be used for the
      analysis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study groups. Agave inulin: 2.3 g twice a day by mouth during 3 months plus recommendations to decrease calories intake an do exercise.
Curcumin: 600 mg (turmeric 600 + black pepper 5 mg) by mouth daily during 3 months plus recommendations to decrease calories intake an do exercise.
Omega-3 fatty acids 600 mg (eicosapentaenoic acid 360; docosahexaenoic acid 240) Three times a day by mouth during 3 months plus recommendations to decrease calories intake an do exercise.
Control group with no intervention. Recommendations to decrease calories intake an do exercise.
Dietary recommendations to ingest 1600 calories per day Exercise: 30 minutes each day, al least 5 days a week (caloric consumption 150-200 kcal per day)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Loosing weight</measure>
    <time_frame>Three months</time_frame>
    <description>Weight lost between basal and third month visits. Determined by a digital scale</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Obesity in Childhood</condition>
  <arm_group>
    <arm_group_label>Agave inulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Agave inulin 2.3 g, by mouth, every 12 hours for 3 months. Plus recommendations to decrease calories intake an do exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curcumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curcumin 600 mg (turmeric 600 + black pepper 5 mg) by mouth, daily for 3 months. Plus recommendations to decrease calories intake an do exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omega 3 Fatty Acids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>O3FA 600 mg (eicosapentaenoic acid 360; docosahexaenoic acid 240) Three times a day by mouth, every 8 hours for 3 months. Plus recommendations to decrease calories intake an do exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Recommendations to decrease calories intake an do exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Agave inulin</intervention_name>
    <description>Will be provided in dehydrated apple cubes</description>
    <arm_group_label>Agave inulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Curcumin</intervention_name>
    <description>Will be provided in capsules</description>
    <arm_group_label>Curcumin</arm_group_label>
    <other_name>Turmeric</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>O3FA</intervention_name>
    <description>Will be provided in capsules</description>
    <arm_group_label>Omega 3 Fatty Acids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Dietary recommendations to ingest 1600 calories per day. Exercise: 30 minutes each day, al least 5 days a week (caloric consumption 150-200 kcal per day)</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gender: Boys and Girls

          -  Diagnosis of obesity (percentile ≥ 95% according to The Centers for Disease Control
             and Prevention growth charts)

          -  Informed consent of parents

          -  Informed assent of the participant

        Exclusion criteria:

          -  Diabetes

          -  Thyroid disease

          -  Renal disease

          -  Hepatic disease

          -  Neoplasia disease

          -  Chronic gastrointestinal conditions

          -  Consume of prebiotics or probiotics

          -  Consume of prebiotics or food supplements

          -  Use of anti-inflammatory drugs.

          -  Recent use of antibiotics (30 days)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Guerrero, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerardo Martinez, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis E Simental, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia I Gamboa, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guerrero</last_name>
    <phone>+526188120997</phone>
    <email>guerrero.romero@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerardo Martinez</last_name>
    <phone>+526188120997</phone>
    <email>uimec@yahoo.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Biomedical Research Unit. IMSS. Durango</name>
      <address>
        <city>Durango</city>
        <state>Dgo</state>
        <zip>34067</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Guerrero, PhD</last_name>
      <phone>+526188120997</phone>
      <email>guerrero.romero@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gerardo Martinez, PhD</last_name>
      <phone>+526188120997</phone>
      <email>uimec@yahoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Luis Simental, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Gluckman P, Nishtar S, Armstrong T. Ending childhood obesity: a multidimensional challenge. Lancet. 2015 Mar 21;385(9973):1048-50. doi: 10.1016/S0140-6736(15)60509-8.</citation>
    <PMID>25797547</PMID>
  </reference>
  <reference>
    <citation>Siró I, Kápolna E, Kápolna B, Lugasi A. Functional food. Product development, marketing and consumer acceptance--a review. Appetite. 2008 Nov;51(3):456-67. doi: 10.1016/j.appet.2008.05.060. Epub 2008 Jun 4. Review.</citation>
    <PMID>18582508</PMID>
  </reference>
  <reference>
    <citation>Tomaschunas M, Zörb R, Fischer J, Köhn E, Hinrichs J, Busch-Stockfisch M. Changes in sensory properties and consumer acceptance of reduced fat pork Lyon-style and liver sausages containing inulin and citrus fiber as fat replacers. Meat Sci. 2013 Nov;95(3):629-40. doi: 10.1016/j.meatsci.2013.06.002. Epub 2013 Jun 10.</citation>
    <PMID>23811098</PMID>
  </reference>
  <reference>
    <citation>Mancilla-Margalli NA, López MG. Water-soluble carbohydrates and fructan structure patterns from Agave and Dasylirion species. J Agric Food Chem. 2006 Oct 4;54(20):7832-9.</citation>
    <PMID>17002459</PMID>
  </reference>
  <reference>
    <citation>González-Herrera SM, Rutiaga-Quiñones OM, Aguilar CN, et al. Dehydrated Apple matrix supplemented with agave fructans, inulin and oligofructose. LWT Food Science and Technology. 2016;65:1059-1065.</citation>
  </reference>
  <reference>
    <citation>López-Velázquez G, Díaz-García L, Anzo A, Parra-Ortiz M, Llamosas-Gallardo B, Ortiz-Hernández AA, Mancilla-Ramírez J, Cruz-Rubio JM, Gutiérrez-Castrellón P. Safety of a dual potential prebiotic system from Mexican agave &quot;Metlin® and Metlos®&quot;, incorporated to an infant formula for term newborn babies: a randomized controlled trial. Rev Invest Clin. 2013 Nov-Dec;65(6):483-90.</citation>
    <PMID>24687355</PMID>
  </reference>
  <reference>
    <citation>Wang SL, Li Y, Wen Y, Chen YF, Na LX, Li ST, Sun CH. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci. 2009 Feb;22(1):32-9. doi: 10.1016/S0895-3988(09)60019-2.</citation>
    <PMID>19462685</PMID>
  </reference>
  <reference>
    <citation>Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors. 2013 Mar-Apr;39(2):197-208. doi: 10.1002/biof.1062. Epub 2012 Dec 13. Review. Erratum in: Biofactors. 2013 Sep-Oct;39(5):591.</citation>
    <PMID>23239418</PMID>
  </reference>
  <reference>
    <citation>Ramírez-Boscá A, Soler A, Carrión MA, Díaz-Alperi J, Bernd A, Quintanilla C, Quintanilla Almagro E, Miquel J. An hydroalcoholic extract of curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech Ageing Dev. 2000 Oct 20;119(1-2):41-7.</citation>
    <PMID>11040400</PMID>
  </reference>
  <reference>
    <citation>Nagwa I, Ragab S, Baky A, et al. Effect of Oral Curcumin Administration on Insulin Resistance, Serum Resistin and Fetuin-A in Obese Children: Randomized Placebo- Controlled study. Reser J of Pharm, Biol and Chem Sci 2014 5:887-96</citation>
  </reference>
  <reference>
    <citation>Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):277-9. doi: 10.1097/MPG.0b013e318276977d.</citation>
    <PMID>23059643</PMID>
  </reference>
  <reference>
    <citation>Huang XF, Xin X, McLennan P, Storlien L. Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obes Metab. 2004 Jan;6(1):35-44.</citation>
    <PMID>14686961</PMID>
  </reference>
  <reference>
    <citation>Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord. 1997 Aug;21(8):637-43.</citation>
    <PMID>15481762</PMID>
  </reference>
  <reference>
    <citation>Juárez-López C, Klünder-Klünder M, Madrigal-Azcárate A, Flores-Huerta S. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents. Pediatr Diabetes. 2013 Aug;14(5):377-83. doi: 10.1111/pedi.12024. Epub 2013 Feb 25.</citation>
    <PMID>23438101</PMID>
  </reference>
  <reference>
    <citation>Parra D, Ramel A, Bandarra N, Kiely M, Martínez JA, Thorsdottir I. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite. 2008 Nov;51(3):676-80. doi: 10.1016/j.appet.2008.06.003. Epub 2008 Jun 14.</citation>
    <PMID>18602429</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2018</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Coordinación de Investigación en Salud, Mexico</investigator_affiliation>
    <investigator_full_name>Fernando Guerrero Romero MD</investigator_full_name>
    <investigator_title>Head of the research unit</investigator_title>
  </responsible_party>
  <keyword>Children, obesity, agave-inulin, curcumin, O3FA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

